DECISIve - DiagnosE Using the Central veIn SIgn v1.0
NCT05533905 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 113
Last updated 2024-03-29
Summary
DECISIve - DiagnosE using the Central veIn SIgn. A prospective diagnostic superiority study comparing T2\* MRI and lumbar puncture in patients presenting with possible Multiple Sclerosis
Conditions
Interventions
- DIAGNOSTIC_TEST
-
Lumbar puncture
A thin needle is inserted between the bones in the spine.
- DIAGNOSTIC_TEST
-
MRI
A scan of the head.
Sponsors & Collaborators
-
Nottingham University Hospitals NHS Trust
lead OTHER
Principal Investigators
-
Nikos Evangelou · NUH NHS Trust
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-12-09
- Primary Completion
- 2023-11-06
- Completion
- 2023-11-06
Countries
- United Kingdom
Study Locations
More Related Trials
-
Single Test to ARrive at MS Diagnosis. Using a Single MRI Brain Scan to Help Diagnose Multiple Sclerosis
NCT02485223 ·Status: UNKNOWN
-
Immunologic Biomarker Profile of Cerebrospinal Fluid
NCT04202055 ·Status: COMPLETED
-
Advanced MRI Sequences in Multiple Sclerosis and Its Mimics
NCT03608605 ·Status: UNKNOWN
-
Use of a Smartphone Application to Predict the Prognosis in Patients With Newly Diagnosed Multiple Sclerosis.
NCT04595799 ·Status: ACTIVE_NOT_RECRUITING
-
Predictive Value of the Optic Nerve Involvement in Clinically Isolated Syndrome
NCT06455332 ·Status: RECRUITING ·Phase: NA
-
Characterization of Cortical Injury in Early MS Patients: a 7T MRI Study
NCT03624296 ·Status: UNKNOWN ·Phase: NA
-
Cortical Inhibition in Patients With Multiple Sclerosis
NCT07128160 ·Status: NOT_YET_RECRUITING
-
Combined Analysis of Inflammatory Biomarkers for CNS Autoimmune Diseases Diagnostic
NCT05056740 ·Status: RECRUITING
-
Evaluation of the Impact of Lesions of the Motor and Proprioceptive Brain and Pan-medullary Pathways on Their Clinically and Electrophysiologically Assessed Function in Multiple Sclerosis
NCT04220814 ·Status: COMPLETED ·Phase: NA
-
Magnetic Resonance Imaging (MRI) to Evaluate Activity of Multiple Sclerosis (MS)
NCT00001248 ·Status: RECRUITING
-
Pregnancy Cohort in Multiple Sclerosis (MS)
NCT05010902 ·Status: RECRUITING
-
Analyze the Myelin-TRAP as Diagnostic Tool in Multiple Sclerosis
NCT01723631 ·Status: TERMINATED ·Phase: NA
-
Multimodal Imaging Signatures of the Biological Mechanisms Underlying Neurodegeneration in Multiple Sclerosis
NCT05633875 ·Status: RECRUITING
-
MRI Biomarkers Predictive of Disability Progression in Patients With Multiple Sclerosis
NCT05491031 ·Status: RECRUITING ·Phase: NA
-
MRI Study of the Mechanisms Underlying Irreversible Disability in Multiple Sclerosis
NCT03356366 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Evaluation of the Clinical Contribution of Quantitative MRI in Neuro-imaging
NCT07245589 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Measuring Silent Disease Progression in Multiple Sclerosis With a Multimodal Approach
NCT06501950 ·Status: RECRUITING
-
Mechanisms of Disease Severity in Multiple Sclerosis: an Integrative Multimodal Study
NCT03369106 ·Status: ACTIVE_NOT_RECRUITING
-
Immunoadsorption Versus High-dose Intravenous Corticosteroids in Relapsing Multiple Sclerosis
NCT04450030 ·Status: UNKNOWN
-
Scan-Rescan Sub-Study of MS PATHS
NCT04123353 ·Status: COMPLETED
-
A Study to Assess the Effects of MK0812 on Disease Activity in Patients With Relapsing-Remitting Multiple Sclerosis as Measured by Magnetic Resonance Imaging (MRI)(0812-003)(COMPLETED)
NCT00239655 ·Status: TERMINATED ·Phase: PHASE2
-
Comparison of Digital Biomarkers in Subjects With Radiologically Isolated Syndrome (RIS) and Multiple Sclerosis (MS) Patients With Clinically Normal Neurological Examination
NCT07135752 ·Status: RECRUITING ·Phase: NA
-
An Observational Biomarker Study in Multiple Sclerosis (MS) Patients
NCT05663853 ·Status: COMPLETED
-
Prognostic Value of Cerebrospinal Fluid Immunoglobulin Free Light Chains in Patients With Multiple Sclerosis
NCT05072691 ·Status: RECRUITING
-
Evaluating Multiple Sclerosis Patients ShOWing A GEnomic Signature of Therapy Response
NCT03316404 ·Status: COMPLETED